UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval
Five things for pharma marketers to know: Friday, November 17, 2017
FDA approves Alexion’s Soliris for another rare disease; Sun Pharma debuts companion mobile app for acne drug; Hurricane halts manufacturing in Puerto Rico
Five things for pharma marketers to know: Thursday, October 19, 2017